PureTech's Akili Pivotal ADHD Trial Successful

By

Regulatory News | 04 Dec, 2017

Updated : 07:05

This regulatory news is for Private Investors only

Last news

Sunday newspaper round-up: Royal Mail, Shein, Canary Wharf
Sunday share tips: Centrica, Lancashire Holdings
Week ahead: Federal Reserve, US non-farm payrolls in the spotlight
Europe close: Alphabet and Microsoft earnings help lift gloom
US close: Nasdaq jumps 2% as tech stocks surge